Loading...
A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discovery
BACKGROUND: Predicting treatment response or survival of cancer patients remains challenging in immuno-oncology. Efforts to overcome these challenges focus, among others, on the discovery of new biomarkers. Despite advances in cellular and molecular approaches, only a limited number of candidate bio...
Na minha lista:
| Udgivet i: | J Immunother Cancer |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8169479/ https://ncbi.nlm.nih.gov/pubmed/34059522 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-002032 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|